1. Andén, N. E., Butcher, S. G., Corrodi, H., Fuxe, K., Ungerstedt: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol.11, 303?314 (1970).
2. Bentley, G. A., Copeland, I. W.: The nature of central?-receptors modulated by chronic haloperidol treatment in cats. Proc. Aust. Soc. Clin. Exp. Pharmacol., December, 1981, Abstract 99.
3. Bousquet, P., Gaertner, M., Feldman, J., Bloch, R.: Variations en fonction de l'anesthesique, des effects de la clonidine sur la pression arterielle du rat. Biol. Comptes rendus5, 1129?1133 (1977).
4. Bousquet, P., Guertzenstein, P. G.: Localization of the central cardiovascular action of clonidine. Brit. J. Pharmacol.49, 573?579 (1973).
5. Carlsson, A., Rosengren, E., Bertler, A., Nilsson, J.: Effect of reserpine on the metabolism of catecholamines. In: Psychotropic Drugs (Garattini, S., Ghetti, V., eds.), Vol. 6, pp. 363?372. Amsterdam: Elsevier. 1957.